# Assessing venous congestion in critical illness: advantages of the inferior vena cava shape change index over diameter

**Authors:** Lizhi Li, Yuehua Xu, Xiukai Chen, Wei Huang

PMC · DOI: 10.1016/j.aicoj.2026.100032 · Annals of Intensive Care · 2026-02-09

## TL;DR

This study shows that a new ultrasound measurement called the Shape Change Index (SCI) of the inferior vena cava is better than traditional diameter measurements for detecting venous congestion in critically ill patients.

## Contribution

The study introduces and validates the SCI as a more reliable indicator of venous congestion compared to IVC diameter.

## Key findings

- The SCI of IVC showed a stronger correlation with venous congestion grade than IVC diameter (Spearman’s ρ = 0.691 vs 0.490).
- SCI demonstrated better diagnostic discrimination (AUC = 0.864) compared to IVC diameter (AUC = 0.767) for detecting venous congestion.
- Higher SCI values were associated with greater disease severity, especially in less advanced stages of venous congestion.

## Abstract

The traditional Venous Excess Ultrasound (VExUS) scoring system relies on inferior vena cava (IVC) diameter measurements, which are affected by multiple confounding factors. The Shape Change Index (SCI) of IVC, defined as the ratio of short-axis diameter to long-axis diameter, may provide a more stable morphological indicator of venous filling.

In this prospective study, trained operators performed bedside ultrasonography to measure IVC diameter and calculate the SCI of IVC (short-axis diameter/long-axis diameter). Hepatic, portal, and renal venous Doppler waveforms were used to grade venous congestion (Grade 0–3). Diagnostic performance of SCI and IVC diameter for detecting venous congestion was evaluated using receiver operating characteristic(ROC) analysis, with additional exploratory analyses performed to further characterize incremental diagnostic value.

A total of 116 venous Doppler examinations from 84 critically ill adults were analyzed. The SCI of IVC demonstrated a stronger correlation with venous congestion grade than IVC diameter (Spearman’s ρ = 0.691 vs 0.490, both p < 0.001). For detecting any venous congestion (VExUS Grade ≥1 vs Grade 0), the SCI of IVC showed significantly better diagnostic discrimination than IVC diameter, with an area under the curve of 0.864 compared with 0.767, respectively (p = 0.044). The diagnostic advantage of SCI appeared to be more evident in examinations without advanced venous congestion. Higher SCI values were associated with greater disease severity.

The SCI of IVC demonstrates superior diagnostic performance compared with IVC diameter for the identification of venous congestion in critically ill patients, particularly at earlier or less advanced stages. These findings support the use of SCI as a complementary screening tool within the existing VExUS framework. Further multicenter studies are required to confirm its clinical utility and generalizability.

## Full-text entities

- **Genes:** GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}
- **Diseases:** Failure (MESH:D051437), chronic kidney disease (MESH:D051436), ventricular dysfunction (MESH:D018754), renal atrophy (MESH:D001284), fluid overload (MESH:D019190), critically ill (MESH:D016638), coronary heart disease (MESH:D003327), Organ Failure (MESH:D009102), AKI (MESH:D058186), Venous congestion (MESH:D006940), CKD (MESH:D012080), congestion (MESH:D002311), atrial fibrillation (MESH:D001281), end-stage renal disease (MESH:D007676), hypovolemia (MESH:D020896), SCI (MESH:C566784), end-stage liver cirrhosis (MESH:D058625), Acute Physiology and Chronic Health (MESH:D000071069)
- **Chemicals:** bilirubin (MESH:D001663), oxygen (MESH:D010100), CVP (MESH:C034588), norepinephrine (MESH:D009638), urea nitrogen (MESH:C530477)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12934418/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12934418/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12934418/full.md

---
Source: https://tomesphere.com/paper/PMC12934418